Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | BMC Veterinary Research

Figure 1

From: In vivo evaluation of mutant selection window of cefquinome against Escherichia coliin piglet tissue-cage model

Figure 1

Effect of cefquinome dose on bacterial inhibition in the tissue-cage model. Tissue-cage implantation and Escherichia coli ATCC 25922 infection were done as described in Materials and Methods. Three days after infection, various doses (0, 0.1, 0.2, 0.4, 0.8, or 1.0 mg/kg of body weight, each piglet has tissue-cages) of cefquinome were administered intramuscular once daily for 5 days (indicated by the arrow). Bacterial colony-forming units in tissue-cage fluid was monitored at 24 h intervals beginning 1 day before the initiation of cefquinome in treatment and ending 2 days after the termination of cefquinome treatment.

Back to article page